Samsara Bio Capital, LLC Alpine Immune Sciences, Inc. Transaction History

Samsara Bio Capital, LLC

  • $194 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$8.19 - $11.31 $2.25 Million - $3.11 Million
-275,169 Closed
0 $0
Q2 2021

Aug 17, 2021
SELL
$8.81 - $15.03 $1.09 Million - $1.86 Million
-124,021 Reduced 31.07%
275,169 $2.48 Million
Q4 2020

Feb 17, 2021
SELL
$7.42 - $15.96 $704,900 - $1.52 Million
-95,000 Reduced 19.22%
399,190 $5.03 Million
Q3 2020

Nov 16, 2020
BUY
$7.15 - $11.5 $3.53 Million - $5.68 Million
494,190 New
494,190 $4.34 Million

Others Institutions Holding ALPN

# of Institutions
2
Shares Held
56.2K
Call Options Held
0
Put Options Held
0
View Full List

About ALPINE IMMUNE SCIENCES, INC.

ALPN Quotes by TradingView
  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Samsara Bio Capital, LLC Portfolio

Follow Samsara Bio Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samsara Bio Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email